Welcome to our dedicated page for MSP Recovery news (Ticker: MSPR), a resource for investors and traders seeking the latest updates and insights on MSP Recovery stock.
MSP Recovery, Inc. (MSPR) generates news that spans healthcare reimbursement recoveries, technology initiatives, litigation developments, capital structure changes, and listing‑status updates. The company describes itself as a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, and its announcements often highlight how legal strategy and data analytics intersect in its business.
Readers following MSPR news can expect detailed updates on reimbursement recovery activities, including settlements with property and casualty insurers, pharmaceutical defendants, and group health plans. The company frequently reports on class actions and other litigation related to the Medicare Secondary Payer Act, as well as court decisions that affect the enforceability of its claim assignments. For example, MSP Recovery has publicized a ruling by the Supreme Court of Maryland upholding its assignment model, and it has described ongoing class action proceedings against a major auto insurer.
MSP Recovery’s news flow also covers technology and platform developments. The company issues updates on its LifeWallet ecosystem, which it says connects patients, providers, and payers, and on LifeChain, its blockchain‑based tokenization platform for medical claims developed with Tokenology Labs. Announcements describe the use of AI, natural language processing, and machine learning, as well as partnerships with technology firms such as Palantir Technologies, Inc.
Investors and observers will also find regular disclosures on capital and restructuring initiatives, including term sheets for new secured term loan facilities, bridge funding arrangements, debt‑to‑equity conversions, and modifications to equity purchase agreements. The company has reported reverse stock splits aimed at addressing Nasdaq bid‑price requirements, notices of non‑compliance with Nasdaq listing standards, and the subsequent decision to delist its common stock from Nasdaq with an expectation of trading on the OTCQB market.
Regulatory and governance topics appear in MSPR’s news as well, such as the conclusion of an SEC investigation without a recommendation of enforcement action, auditor transitions affecting filing timelines, and settlements that resolve previously disclosed litigation risks. For a consolidated view of these developments, the MSPR news page provides a chronological archive of company‑issued updates and related regulatory disclosures.
MSP Recovery has announced the release of its Q3 2022 financial results, scheduled for November 8, 2022, after market close. This leading company in healthcare reimbursement recovery will conduct a conference call and live webcast at 8:00 a.m. ET on November 9, 2022, to discuss the results with investors and analysts. Participants can pre-register for the call via the provided link. The webcast will be available on the company’s website, with a replay accessible after the event.
Founded in 2014, MSP Recovery focuses on innovative solutions for Medicare, Medicaid, and commercial recovery.
MSP Recovery, Inc. (NASDAQ: MSPR) announced a licensing agreement generating an initial $7.5 million fee and annual fees of $1 million from a new client utilizing its LifeWallet platform. The platform integrates health records, biometrics, and blockchain technology. Additionally, MSPR amended a contract with Brickell Key Investments, reducing debt by $63 million and halting $40 million in annual interest accrual. This move signifies a strategic shift towards enhancing liquidity and supporting ongoing technology deployment in healthcare.
On September 22, 2022, MSP Recovery (MSPR) announced significant business growth by partnering with healthcare provider networks, expanding its reach to over 1,800 providers and 30 outpatient sites. The company reported initial payments averaging 284% of the Paid Value of Potentially Recoverable Claims (PVPRC), with previous settlements achieving up to 600%. MSPR is launching the LifeWallet Legal Referral Service, aimed at enhancing revenue streams. This update highlights MSPR's commitment to innovating healthcare reimbursement solutions and leveraging technology for increased efficiency.
MSP Recovery, Inc. (NASDAQ: MSPR) has reported significant growth, expanding from 11,000 to over 34 million unique healthcare member lives since 2014, with an additional 3 million expected by September 30, 2022. The company has developed advanced blockchain technology in collaboration with Tokenology, enhancing transaction transparency and efficiency. Furthermore, a partnership with Palantir has facilitated the creation of a state-of-the-art healthcare analytics tool, optimizing claims management and recovery processes. CEO John H. Ruiz highlighted the firm's progress in technology initiatives aimed at increasing revenue and operational efficiency.
MSP Recovery (NASDAQ: MSPR) reported substantial asset growth, increasing from $104 million at the end of 2021 to $6.6 billion by June 30, 2022. The company announced a total revenue of $5.3 million for Q2 2022, a 57% increase year-over-year. However, it faced an operating loss of $52.2 million and a net loss of $77.1 million. MSPR's recoverable claims grew to a potential value of $88.3 billion, showing promise for future revenues. MSPR has secured approximately $1.5 billion in capital resources and aims for total gross recoveries of $992 million for 2022.
MSP Recovery (NASDAQ: MSPR) announced a pilot program for its Health Safety Technology at Cano Health, which serves over 270,000 members. The LifeWallet portal will help Cano Health identify patient medical histories and payer information in real-time, enhancing operational efficiency and potentially lowering costs. This integration includes biometric check-ins to prevent improper medical documentation. The initiative aims to improve patient care through data analytics, ultimately benefiting both patients and providers.
MSP Recovery, a leader in Medicare, Medicaid, and reimbursement recovery, will release its Q2 2022 financial results on August 11, 2022, before market opening. A webcast and conference call will follow at 8:30 a.m. ET to discuss the results and recent developments. Callers can join via U.S. number 1-866-652-5200 or internationally at 1-412-317-6060. The event is accessible through the MSP Recovery's website and replays will be available through November 11, 2022.
MSP Recovery, Inc. (NASDAQ: MSPR) announced a significant ruling from the U.S. Circuit Court of Appeals for the Eleventh Circuit on July 18, 2022, in the case MSP Recovery Claims, Series LLC v. Metropolitan General Insurance Company. The court overturned a previous dismissal, affirming that Metropolitan has a "demonstrated responsibility" to pay claims under the Medicare Secondary Payer Act. This decision is pivotal, as it may influence other ongoing litigations involving MSP Recovery. The firm aims to challenge the outdated healthcare reimbursement system, enhancing compliance and recovery solutions.
On July 18, 2022, MSP Recovery, Inc. (NASDAQ: MSPR) won a crucial ruling from the U.S. Circuit Court of Appeals for the Eleventh Circuit. The court overruled a previous Southern District Court decision, affirming MSP Recovery's claim that Metropolitan General Insurance has a "demonstrated responsibility" to reimburse conditional payments made under the Medicare Secondary Payer Act. This ruling is expected to influence ongoing lawsuits involving MSP Recovery, enhancing their position in future claims.
MSP Recovery (NASDAQ: MSPR) announced an agreement with Prudent Group to monetize up to $250 million in its Net Recovery Proceeds. This strategic relationship aims to enhance access for European investors in the U.S. healthcare industry. MSPR has been sending individual claim demand letters to insurers, which led to a rise in payments received. The deal enables Prudent Group to acquire a percentage of MSPR's recovery rights on a non-recourse basis, specifically targeting individual demand letters.